Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.
Comera Life Sciences has raised $4.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2023.
Comera Life Sciences's investors include KBI Biopharma, Phoenix Venture Partners.
Comera Life Sciences is headquartered in Woburn, United States.
Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.
Comera Life Sciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Comera Life Sciences — Funding & Investors." VCBacked, August 1, 2023, https://www.vcbacked.co/company/comera-life-sciences. Accessed September 30, 2026.
VCBacked. (2023). Comera Life Sciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/comera-life-sciences
{{cite web |title=Comera Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/comera-life-sciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated